Skip to content

Based on Delphi Method to Preliminarily Construct a Recommended Protocol for the Prevention of Novel Coronavirus Pneumonia (COVID-19) in Deyang Area by Using Chinese Medicine Technology and its Clinical Application Evaluation

Based on Delphi Method to Preliminarily Construct a Recommended Protocol for the Prevention of Novel Coronavirus Pneumonia (COVID-19) in Deyang Area by Using Chinese Medicine Technology and its Clinical Application Evaluation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000029821
Enrollment
Unknown
Registered
2020-02-14
Start date
2020-02-14
Completion date
Unknown
Last updated
2020-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Observation group:TCM prevention
Health education unit:Health education

Sponsors

Deyang Integrated Traditional Chinese and Western Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Non suspected cases and non confirmed cases; 2. Participate in novel coronavirus front-line prevention and control of medical staff, street community office staff; 3. Novel coronavirus pneumonia is recommended by people who voluntarily accept TCM technology.

Exclusion criteria

Exclusion criteria: 1. Suspected cases and confirmed cases; 2. Patients with severe heart, brain, liver, kidney and other visceral diseases or other serious metabolic disorders and tumors; 3. People who could not complete the study for other reasons; 4. Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
CD4+;CD3+;HAMA;HAMD;STAI;

Secondary

MeasureTime frame
Safety evaluation;

Countries

China

Contacts

Public ContactQiu Jun

Deyang integrative medicine hospital

973007530@qq.com+86 13881070630

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026